23 May 2013
Keywords: vioxx, different, cox-2s, study, new, published, atherosclerosis
Article | 22 November 2004
A new study published in Atherosclerosis suggests that there are important differences between Merck & Co's Vioxx (rofecoxib) and other
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 November 2004
15 November 2004
22 May 2013
© 2013 thepharmaletter.com